Skip to main content
. Author manuscript; available in PMC: 2018 Aug 14.
Published in final edited form as: ACS Biomater Sci Eng. 2017 Jun 21;3(8):1641–1653. doi: 10.1021/acsbiomaterials.7b00166

Figure 5.

Figure 5

In vivo assessment of antitumor effects of DH/5-FU. (A) Change of relative tumor volume [ratio of mouse tumor volume (V) to initial tumor (V0)] was monitored over the course of treatment. (B) The survival was estimated by using Kaplan–Meier analysis. (C) Body weights of mice in all groups were recorded. Arrow bars indicate the days when the mice were given injection. ** p < 0.01 vs. the PBS and DH groups.